Furthermore, the involvement of the farnesoid X receptor (fxr) as a key molecular switch to regulate bile acid synthesis and thus the progression of NASH has also recently received attention [9,10]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.